In This Section
- Home
- What We Do
- New Ventures Wall
- KT Boost
- Entrepreneur in Residence Programme
- Impact Success Stories
- Guide for Inventors
- Commercialisation
- Considerations for a Spin-out Company
- Invention Disclosures
- Licenses and Other Agreements
- Marketing to Find a License
- Ownership of Intellectual Property
- Assessment of an Invention Disclosure
- Patents and other Legal Protection
- Reinvestment and Relationships
- Revenue Distributions
- What is Technology Transfer
- The Team
- Find a Case Manager
- Impact Report
- Entrepreneurs
- Researchers
- Industry
- Investors & Mentors
- Students & Recent Graduates
- News & Events
- Contact us
UCC spin-out CergenX awarded €6.7 million funding for their 'CergenX Wave device'
A new technology to screen newborns for brain injury has been awarded €6.7million in funding from the Disruptive Technology Innovation Fund (DTIF). The major investment will support scientists and engineers to advance brain health monitoring for newborn babies. The Irish Centre for Maternal and Child Health Research (INFANT) at University College Cork with UCC spin-out CergenX and Evervault were awarded €6.7million for the CergenX Wave Device, which will develop a novel platform to detect abnormal brain activity in infants soon after birth through an automated AI assessment.
UCC Innovation
Aistriú Nualaíocht
Contact us
Room 2.44, Western Gateway Building, Western Road, Cork, Ireland, T12 XF62